Dai Manaka

Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer

Takayuki Yoshino, Takeharu Yamanaka, Eiji Oki et al. · JAMA Oncology · 2019 · 96 citations · Full text

A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer

Suguru Hasegawa, Saori Goto, Takuya Matsumoto et al. · Annals of Surgical Oncology · 2017 · 72 citations

Radiation Therapy, Medicine, Cancer Recurrence +7

Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)

Eiji Oki, Yasunori Emi, Takeharu Yamanaka et al. · British Journal of Cancer · 2019 · 58 citations · Full text

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial

Kentaro Yamazaki, Takeharu Yamanaka, Manabu Shiozawa et al. · Annals of Oncology · 2020 · 50 citations · Full text

Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein

Yoshio Yamaoka, Kaoru Kumada, Keiichi Ino et al. · World Journal of Surgery · 1992 · 49 citations